I'm LongbridgeAI, I can summarize articles.Boston Scientific Corp. (BSX) shares rose 2.33% to $50.46, outperforming the broader market which saw declines in the S&P 500 and Dow Jones. This marks the stock's third consecutive day of gains. While competitors like Abbott, Medtronic, and Stryker also posted modest increases, Boston Scientific's trading volume remained below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Boston Scientific Corp. (BSX) advanced 2.33% to $50.46 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.06% to 7,753.11 and Dow Jones Industrial Average falling 0.11% to 53,975.98.
This was the stock's third consecutive day of gains.
Boston Scientific Corp. closed 53.92% short of its 52-week high of $109.50, which the company achieved on September 9th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories (ABT) rose 0.75% to $108.62, Medtronic PLC (MDT) rose 2.58% to $89.41, and Stryker Corp. (SYK) rose 2.00% to $345.81.
Trading volume (18.9 M) remained 2.4 million below its 50-day average volume of 21.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 10, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-10-26 1646ET